4.6 Review

Current Status of Evidence for a New Diagnosis: Food Addiction-A Literature Review

Journal

FRONTIERS IN PSYCHIATRY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fpsyt.2021.824936

Keywords

food addiction; behavioral addiction; sugar addiction; eating addiction; obesity

Categories

Ask authors/readers for more resources

Food addiction is an important aspect in understanding psychiatric and medical problems related to eating behaviors, such as obesity and eating disorders. It has similarities with other eating disorders but lacks specific diagnostic criteria. The disorder is associated with reward dysfunction, impulsivity, and emotion dysregulation, and may have genetic factors involved. Further clinical trials are needed to evaluate the efficacy of treatment options.
Food addiction is considered an important link for a better understanding of psychiatric and medical problems triggered by dysfunctions of eating behaviors, e. g., obesity, metabolic syndrome, binge eating disorder, or bulimia nervosa. At behavioral level, food addiction has high degrees of similarity with other eating disorders, a phenomenon that creates difficulties in finding specific diagnostic criteria. Food addiction has been also described as eating addiction or eating dependence by several researchers, who placed the emphasis on the behavior and not on the food itself. High-sodium foods, artificially flavored-foods, rich carbohydrate- and saturated fats-containing foods are triggers for the activation of the same neural pathways, therefore they act similarly to any drug of abuse. Food addiction is considered a disorder based on functional negative consequences, associated distress and potential risks to both psychological well-being and physical health. A clinical scale was validated for the quantification of the eating addiction severity, namely the Yale Food Addiction Severity Scale (YFAS), constructed to match DSM IV criteria for substance dependence. Using this instrument, a high prevalence of food addiction was found in the general population, up to 20% according to a meta-analytic research. The pathogenesis of this entity is still uncertain, but reward dysfunction, impulsivity and emotion dysregulation have been considered basic mechanisms that trigger both eating dysfunctions and addictive behaviors. Genetic factors may be involved in this dependence, as modulators of higher carbohydrate and saturate fat craving. Regarding the existence of potential therapeutic solutions, lorcaserin, antiepileptic drugs, opioid antagonists, antiaddictive agents are recommended for obesity and eating disorders, and they may be intuitively used in food addiction, but clinical trials are necessary to confirm their efficacy. In conclusion, a better understanding of food addiction's clinical profile and pathogenesis may help clinicians in finding prevention- and therapeutic-focused interventions in the near future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Medicine, General & Internal

Is fecal microbiota transplantation a useful therapeutic intervention for psychiatric disorders? A narrative review of clinical and preclinical evidence

Octavian Vasiliu

Summary: Research suggests that modulation of the intestinal microbiota may be beneficial for specific psychiatric disorders. However, most of the evidence comes from preclinical studies, and further clinical trials with robust methodology and larger sample sizes are needed to validate the benefits and risks.

CURRENT MEDICAL RESEARCH AND OPINION (2023)

Review Health Care Sciences & Services

State of the Art and Challenges in Epilepsy-A Narrative Review

Aida Mihaela Manole, Carmen Adella Sirbu, Mihaela Raluca Mititelu, Octavian Vasiliu, Lorenzo Lorusso, Octavian Mihai Sirbu, Florentina Ionita Radu

Summary: Epilepsy affects approximately 50 million people worldwide, and a single seizure does not necessarily indicate epilepsy. There are many other central nervous system disorders that can cause seizures, leading to a widespread and often underestimated impact. Correct diagnosis and treatment could potentially make 70% of epilepsy patients seizure-free, but their quality of life is also influenced by factors such as adverse reactions to antiepileptic drugs, access to education, mood, employment, and transportation.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Review Chemistry, Medicinal

Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder-A Narrative Review

Octavian Vasiliu

Summary: The estimated rate of treatment-resistant major depressive disorder (TRD) remains higher than 30%, even after the discovery of multiple classes of antidepressants in the last 7 decades. Toludesvenlafaxine (ansofaxine, LY03005, or LPM570065) is a first-in-class triple monoaminergic reuptake inhibitor (TRI) that has reached clinical use. This review summarizes the clinical and preclinical evidence for the efficacy, tolerability, and safety of toludesvenlafaxine, highlighting its positive results in short-term trials but indicating the need for more research on larger samples and longer durations.

PHARMACEUTICALS (2023)

Review Psychology, Multidisciplinary

The complex interplay between psychosocial and biological factors in pregorexia nervosa - a rapid review

Octavian Vasiliu

Summary: The importance of detecting and treating eating disorders during pregnancy is crucial due to the significant negative impact on both maternal and fetal health. However, there are limitations in understanding the diagnostic criteria, risk factors, and mechanisms, necessitating further research for specific diagnostic criteria and treatment approaches.

FRONTIERS IN PSYCHOLOGY (2023)

Article Nutrition & Dietetics

Current trends and perspectives in the exploration of anorexia athletica-clinical challenges and therapeutic considerations

Octavian Vasiliu

Summary: Elite athletes face significant physical and psychological stress throughout their careers, but the research on the impact of this stress on their mental health is still in early stages. Eating disorders, substance use disorders, and behavioral addictions are areas that require further investigation to develop prevention and treatment strategies. In particular, the exploration of eating disorders in athletes is important due to the vulnerability of this population to weight and body shape issues and the higher prevalence of eating disorders compared to the general population. This article synthesizes available data on a specific disorder, anorexia athletica, including risk factors, diagnosis, and treatment, highlighting the need for more research on the physical and mental health of elite athletes, especially in esthetic sports.

FRONTIERS IN NUTRITION (2023)

Meeting Abstract Clinical Neurology

Combined pharmacological and psychosocial management of nicotine use disorder in patients diagnosed with severe mental disorders

Daniel Vasile, Octavian Vasiliu, Diana Vasiliu

BIPOLAR DISORDERS (2023)

Meeting Abstract Clinical Neurology

Cannabinoids in the therapeutic management of mood disorders

Daniel Vasile, Octavian Vasiliu, Andrei Gabriel Mangalagiu, Bogdan Mircea Petrescu, Cristian Alexandru Candea, Corina Tudor, Roxana Elena Bratu-Bizic, Andreea Filareta Fainarea, Mihaela Cristina Patrascu

BIPOLAR DISORDERS (2023)

Meeting Abstract Clinical Neurology

Health-related quality of life in elderly patients with bipolar disorder

Octavian Vasiliu

BIPOLAR DISORDERS (2023)

Meeting Abstract Psychiatry

Internet gambling disorder - A case series

Octavian Vasiliu, Diana Gabriela Vasiliu

JOURNAL OF BEHAVIORAL ADDICTIONS (2023)

Meeting Abstract Psychiatry

Internet pornography addiction - Therapeutic approaches and case management challenges

Octavian Vasiliu

JOURNAL OF BEHAVIORAL ADDICTIONS (2023)

Meeting Abstract Psychiatry

Next-generation antipsychotics- Trends and perspectives beyond dopaminergic and glutamatergic agents

O. Vasiliu, A. G. Mangalagiu, B. M. Petrescu, C. A. Candea, C. Tudor, D. Ungureanu, M. Miclos, C. Florescu, A. I. Draghici, R. E. Bratu-Bizic, M. Dobre, A. F. Fainarea, M. C. Patrascu

EUROPEAN PSYCHIATRY (2023)

Meeting Abstract Psychiatry

Evaluation of the executive dysfunction in patients with bipolar disorder

O. Vasiliu

EUROPEAN PSYCHIATRY (2023)

No Data Available